Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.425 EUR | -1.04% | -18.60% | -8.20% |
Business Summary
Number of employees: 76
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies
100.0
%
| 31 | 100.0 % | 6 | 100.0 % | -80.69% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Germany
100.0
%
| 25 | 80.4 % | 6 | 100.0 % | -75.97% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Selwyn Ho
CEO | Chief Executive Officer | 53 | 22-07-24 |
Chief Tech/Sci/R&D Officer | - | 14-04-30 | |
Pamela Keck
IRC | Investor Relations Contact | - | 23-01-31 |
Christian Schmid
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-08-11 | |
Frank Mathias
BRD | Director/Board Member | 62 | 18-05-14 |
Anthony Man
BRD | Director/Board Member | 68 | 20-12-15 |
Gerd Zettlmeissl
CHM | Chairman | 68 | 16-12-31 |
Ronald Scott
BRD | Director/Board Member | 69 | 17-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,562,658 | 23,692,545 ( 96.46 %) | 0 | 96.46 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.20% | 37.9M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.63% | 22.18B | |
-16.67% | 21.2B | |
-8.56% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- MDG1 Stock
- Company Medigene AG